🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,931 results for “The” Clear

  1. Chloroprocaine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anesthesia

    approved small molecule completed

    1 trial

  2. Chloroquine

    United Therapeutics Europe Ltd

    Malaria, Falciparum

    approved small molecule completed

    1 trial

  3. Chocolate PTA Balloon

    Blackmores Limited

    Atherosclerosis

    approved other active

    1 trial

  4. Cholecalciferol

    The First People's Hospital of Lianyungang

    Peritoneal Dialysis-associated Peritonitis

    approved small molecule active

    1 trial

  5. Cholecalciferol

    United Therapeutics Europe Ltd

    Crohn Disease

    approved other active

    1 trial

  6. Cilostazol

    The First People's Hospital of Lianyungang

    Cerebral Small Vessel Disease

    approved small molecule active

    1 trial

  7. Cinacalcet

    The University of Hong Kong

    Kidney Failure

    approved small molecule completed

    1 trial

  8. Cinobufacini injection

    The First People's Hospital of Lianyungang

    Liver Cancer

    approved small molecule active

    1 trial

  9. Ciprofloxacin

    Iterum Therapeutics plc

    UTI - Lower Urinary Tract Infection

    approved small molecule completed

    1 trial

  10. Ciprofol

    The First People's Hospital of Lianyungang

    ECMO Treatment

    approved small molecule active

    1 trial

  11. Ciprofol

    The First People's Hospital of Lianyungang

    Postoperative Delirium (POD)

    approved small molecule active

    1 trial

  12. Clensia polvo para solución oral., CitraFleet Polvo para solución oral en sobre

    The George Institute

    colorectal cancer early detection

    approved small molecule active

    1 trial

  13. Coartem™ (Artemether-lumefantrine combination)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial

  14. Cohort A will receive an initial load dose of 8mg/kg and a maintenance dose of 6mg/kg intravenously on the first day of every three weeks for a total of 4 doses

    The First People's Hospital of Lianyungang

    HER2 Positive Breast Cancer

    approved small molecule active

    1 trial

  15. Combination of antiplatelet drugs and anticoagulants for at least one month

    The First People's Hospital of Lianyungang

    Acute Myocardial Infarction

    approved small molecule active

    1 trial

  16. Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 0.2 mg/mL dispersion for injection COVID-19 mRNA Vaccine, EVUSHELD 150 mg + 150 mg solution for injection, Xevudy 500 mg concentrate for solution for infusion, Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

    The George Institute

    Covid-19 infection

    approved small molecule active

    1 trial

  17. Commercial Hylenex® recombinant (hyaluronidase human injection)

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  18. Conducted AF-Response Algorithm (CAFR) On

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other terminated

    1 trial

  19. Control: Femoral perineural local anesthetic infusion

    Summit Therapeutics

    Postoperative Pain Following Knee Arthroplasty

    approved small molecule completed

    1 trial

  20. Conventional therapy + S (+)-Ketamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    S-ketamine

    approved small molecule active

    1 trial

  21. Copper IUD

    United Therapeutics Europe Ltd

    Mucosal Inflammation

    approved small molecule completed

    1 trial

  22. Cosyntropin

    United Therapeutics Europe Ltd

    Postdural Puncture Headache

    approved small molecule completed

    1 trial

  23. CrossBoss Catheter

    United Therapeutics Europe Ltd

    Arteriosclerosis

    approved other completed

    1 trial

  24. Cyclogest 400 mg óvulos

    The George Institute

    Infertility

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources